04
Mar
Australia spotlight: Time for action
Australia buyout activity has stuttered in recent years, especially in the large-cap space – a consequence of rising costs, slower growth, and global macro uncertainty. Now, though, the economic outlook appears stable, with a gradual uptick in growth, manageable inflation, and low unemployment. Private equity investors must pick their spots carefully, but recent performance suggests they’ve done that well. With numerous mid-cap GPs hitting the fundraising trail, there’s motivation to make an impression in 2026.
- Which sectors can be relied upon to deliver both growth and resilience?
- How do GPs position companies for exits?
- To what extent are Australian managers targeting different types of LP?
- What has been the impact of increased regulatory focus on valuations?
-
SpeakersAngus Kilian Director, Private Funds for APAC, ME & Africa Carta
Mark Chudek Partner and Head of Australia/NZ Affinity Equity Partners
Jeremy Samuel Managing Director Anacacia Capital
Matt Robinson Managing Director - Private Equity Pacific Equity Partners
Vincent Wong Partner & Co-Head of Healthcare TPG Asia
Loading feed
Lead Sponsors
Asia Series Sponsor
Co-Sponsors
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports
Angus Killian is the Director of Sales & Go-To-Market for private funds at Carta, Asia Pacific, Middle East and Africa. Carta is the ERP for private capital, connecting the entire ecosystem–from GPs and LPs to CEOs, CFOs, employees, and advisors. Its fund administration platform supports over 8,500 funds and SPVs, representing more than $182B in assets under administration, with tools designed to enhance the strategic impact of Fund CFOs.
During his 7 years with Carta based in San Francisco and Sydney, he has focused on incubating and scaling new products and entering new markets. Notably, he led the go-to-market strategy for a pioneering financial reporting product tailored for the Private Equity industry, successfully driving the product from inception to $25 million in ARR within just four years.
Prior to joining Carta, Angus honed his expertise in enterprise sales at LinkedIn, following a career as a corporate lawyer at the global law firm DLA Piper. His diverse background in law, sales, and testing product-market fit position him as a valuable advisor to the private markets ecosystem.
Mark Chudek is a Partner of Affinity Equity Partners and Head of its Australian and New Zealand investment team.
Mark is a member of Affinity’s investment committee and first joined Affinity in 2013. Prior to rejoining Affinity in 2023, Mark spent 2 years at Quadrant Private Equity within Quadrant’s flagship buyout fund between 2021 and 2023.
Before Mark’s private equity career commenced in 2013, he spent 3 years at Credit Suisse within their investment banking team in Sydney.
Mark’s private equity career spans 7 completed platform investments, serving on 14 investee company boards, completing 20 financings across his portfolio of investee companies and exiting 4 platform investments.
Jeremy Samuel is the founder and Managing Director of Anacacia Capital.
Anacacia manages >$1B investing into leading small-medium enterprises. This includes five series of private equity funds focused on Australasian lower mid-market growth buyouts. Anacacia has won numerous awards including the Australian Investment Council Firm of the Year.
Jeremy is a non-executive director of Anacacia portfolio companies: Sureway, MGI Golf and Opteon. He was the former lead director for Anacacia's successful investments including: Appen, Big River, Home Appliances, Lomb Scientific, Rafferty's Garden and Yumi's Quality Foods.
Jeremy holds an MBA from Yale University School of Management and Arts/Law degrees from the University of NSW.
Matt joined Pacific Equity Partners in 2009. Prior to joining PEP, he was a consultant with Bain & Company in Australia. Matt was an Innovation Scholar at Macquarie University where he received a Bachelor of Commerce (Actuarial Studies) and was awarded the Vice Chancellor’s Commendation for Academic Excellence.
Vincent Wong is a Partner with TPG and Co-Head of Healthcare for TPG Capital Asia, based in Melbourne. In addition to healthcare, Vincent also focuses on consumer investments for TPG Capital Asia in Australia. Vincent currently has responsibilities for TPG’s investments in Invocare, iNova, Funlab, Greencross, and Novotech, and previously for exited investments including Inghams and Healthscope.
Prior to joining TPG in 2011, Vincent served in the Investment Banking Division at Goldman Sachs & Co. Vincent graduated from The University of Melbourne with BCommerce and BLaws (Honors).